Eating more soy-rich foods could reduce spread of breast cancer - UU research

September 23, 2004

Eating more soy-rich foods could reduce the spread of breast cancer - a new study from the University of Ulster has revealed.

Dr Pamela Magee, from the School of Biomedical Sciences, has been investigating the effects of a group of dietary compounds, found almost exclusively in soy foods, in the prevention of cancer spread.

Dr Magee said: "Breast cancer is the most common form of cancer affecting women in the western world, with 950 women in Northern Ireland alone suffering from the disease per year.

"But among South-East Asian populations, and in areas where soy products are traditionally consumed in high amounts in the diet, incidence of breast cancer is low.

"Soy contains naturally occurring hormone-like compounds called isoflavones that scientists believe can inhibit breast cancer development.

"In our study we used cell cultures to examine the effects of isoflavones on the invasion of breast cancer cells. The isoflavones exerted potent inhibitory effects on breast cancer cell invasion, even at concentrations similar to those found in South East-Asian populations.

"These novel findings seem to indicate that eating a soy rich products such as soy milk, soy drinks and desserts, could have an important role in preventing the spread of cancer cells in the body. Further studies in human volunteers are now needed to confirm whether soy isoflavones will protect against breast cancer spread in patients.

"Although recent advances have been made in tumour detection and treatment, the spread of cancer remains a significant cause of mortality. The invasion of cancerous cells from their site of origin into the neighbouring environment enables cancerous cells to travel and grow at new sites within the body. Any agent, therefore, which can prevent the invasive process could become a powerful tool in the prevention of cancer spread."
-end-
Notes to editor:

This study was carried out with financial support from the Commission of the European Communities specific RTD programme "Quality of Life and Management of Living Resources" (project no QLK-2000-00266). It does not necessarily reflect its views and in no way anticipates the Commission's future policy in this area.

For further information contact: Trina Porter, Press Officer, University of Ulster, 44-289-036-8390

University of Ulster

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.